Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 18.34
+0.26 (1.44%)
At close: Mar 6, 2026
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 10.53 billion as of March 6, 2026. Its market cap has decreased by -10.75% in one year.
Market Cap
10.53B
Enterprise Value
7.72B
Revenue
1.65B
Ranking
n/a
PE Ratio
53.94
Stock Price
18.34
Market Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 10.53B, a decrease of -77.32%. That is a compound annual growth rate of -23.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 10.38B | -4.39% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autek China | 13.56B |
| Micro-Tech (Nanjing) Co.,Ltd | 13.45B |
| Tofflon Science and Technology Group | 12.69B |
| Jiangsu Hualan New Pharmaceutical Material | 12.29B |
| Eyebright Medical Technology (Beijing) | 10.98B |
| Tinavi Medical Technologies | 10.87B |
| Aidite (Qinhuangdao) Technology | 8.77B |
| Hubei Huaqiang High-Tech | 8.08B |